AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 81(4), 2009, pp. 695-697
doi:10.4269/ajtmh.2009.09-0252;
Copyright © 2009 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Smythe, L. D.
Right arrow Articles by Peacock, S. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smythe, L. D.
Right arrow Articles by Peacock, S. J.

SHORT REPORT


The Microscopic Agglutination Test (MAT) Is an Unreliable Predictor of Infecting Leptospira Serovar in Thailand

Lee D. Smythe, Vanaporn Wuthiekanun*, Wirongrong Chierakul, Yupin Suputtamongkol, Surapee Tiengrim, Michael F. Dohnt, Meegan L. Symonds, Andrew T. Slack, Apichat Apiwattanaporn, Sunee Chueasuwanchai, Nicholas P. Day, AND Sharon J. Peacock
WHO/FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis, Western Pacific Region, Communicable Disease Unit, Queensland Health Scientific Services, Brisbane, Australia; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand; Medical Department, Udon Thani Reginal Hospital, Udon Thani, Thailand

 

ABSTRACT

A prospective study in Thailand identified 106 patients with culture-proven leptospirosis. The accuracy of the microscopic agglutination test (MAT) in predicting the infecting serovar was evaluated in 78/106 (74%) patients with a diagnostic titer. MAT correctly determined the infecting serovar in 26 cases (33%), indicating that this assay is a poor predictor of infecting serovar in our setting.


Leptospirosis is an acute febrile illness caused by pathogenic members of the genus Leptospira . This disease has a worldwide distribution but is most common in tropical regions, including Thailand.15 In a prospective observational study of undifferentiated fever in 845 patients in rural Thailand, leptospirosis was reported to be responsible for 36.9% of cases.4 Leptospira isolation is the gold standard for confirmation of leptospirosis in humans. This provides definitive identification of the infecting serovar and is an important technique for the study of outbreaks and global epidemiology. It has a number of significant drawbacks, however, including low diagnostic sensitivity, prolonged culture period, and the associated expertise necessary for identification of the infecting serovar together with related costs.

The microscopic agglutination test (MAT) is commonly used to reach a serologic diagnosis of leptospirosis and is performed by detecting agglutinating antibodies by mixing patient serum with a panel of Leptospira serovars that are considered to be representative of the endemic strains for a given region.3 A positive diagnostic result for the MAT is a 4-fold change in titer or a single pre-defined titer. MAT has also been used to provide an indication of the presumptive serovars causing leptospirosis in a given region. The ability of MAT to accurately determine the prevalent serovars was called into question by a retrospective study conducted in Barbados where disease in 151 individuals was caused by four serovars (L. kirschneri serovar Bim, L. interrogans serovar Copenhageni, L. borgpetersenii serovar Arborea, and L. noguchii serovar Bajan); serologic analysis was found to have a low degree of accuracy for determining the infecting serovar in this setting.6 The epidemiology of infecting isolates in Thailand differs markedly, with a recent study showing that the majority of human disease was caused by L. interrogans serovar Autumnalis.7 The aim of this study was to determine whether MAT provides an accurate guide to the infecting serovars of Leptospira in Thailand.

A prospective study was conducted in hospitals situated in six provinces in northeast Thailand (Udon Thani, Burirum, Loei, Nakhon Ratchasima, Maha Sarakham, and Yasothon) between October 2000 and December 2006 to identify patients with culture proven leptospirosis. The study protocol was approved by the Ethical Committee of the Ministry of Public Health, Royal Government of Thailand. Admitting physicians were asked to recruit patients of all ages who they suspected on clinical grounds to have leptospirosis. Clinical features considered were those specifically referred to in the national guidelines (fever with chills and headache together with at least one of the following symptoms or signs: severe muscle pain or muscle tenderness especially calf muscle, meningism or alteration of consciousness, conjunctival suffusion, dry cough, hemoptysis).8 A 10-mL blood sample was collected into a sterile tube containing 250 units of heparin sodium (Heparin Leo; Leo Pharma, Buckinghamshire, UK) for Leptospira culture on the day of admission. A further 5-mL sample was taken on admission and again during the convalescent period for serologic testing using the MAT. Serum was stored at –80°C until analysis. Leptospira culture was performed using Ellinghausen McCullough Johnson Harris (EMJH) medium (Difco Laboratories, BD, NJ) supplemented with 3% rabbit serum and 0.1% agarose, as previously described.9 Positive cultures were sent to the WHO/ FAO/OIE Collaborating Center for Reference & Research on Leptospirosis, Australia, for serovar identification using the cross-agglutinin absorption test (CAAT). 10 MAT was performed by the WHO/FAO/OIE Collaborating Center for Reference and Research on Leptospirosis, Australia, as previously described, 10 using a live panel of antigens representing both ubiquitous and locally prevalent serovars (Table 1Go). A positive MAT was taken as a single titer of ≥ 1:400 or more or a 4-fold rise in titer between acute and convalescence samples taken up to 60 days after the onset of symptoms.


View this table:
[in this window]
[in a new window]

 
TABLE 1
List of Leptospira isolates used in the microscopic agglutination test

 
A total of 149 patients with culture-proven leptospirosis known to be infected with a defined serovar were recruited during the study period. Median age was 35 years (range, 13–72 years; interquartile range [IQR], 25–47 years); 81% were men. The median duration of symptoms before hospital presentation was 3 days (range, 1–8 days; IQR, 2–4 days). Five patients (3%) died during hospital admission. A second serum sample was not collected in 43 patients; this included the 5 fatal cases and 38 patients (26%) who were lost to follow-up. None of these 43 patients had a raised titer on the admission sample. These 43 patients were excluded from further analysis. Convalescent samples were obtained from the remaining 106 cases a median of 15 days (range, 3–53 days; IQR, 9–20 days) after the onset of symptoms. Convalescent samples were used for assigning serovar specificity of MAT.

The seven serovars identified by CAAT for the 106 infecting Leptospira were as follows: L. interrogans serovar (sv.) Autumnalis, 91 isolates (86%); L. interrogans sv. Pyrogenes, 7 isolates (7%); L. borgpetersenii sv. Javanica, 3 isolates (3%); L. interrogans sv. Medanensis, 2 isolates (2%); L. interrogans sv. Bataviae, 1 isolate (1%); L. interrogans sv Pomona, 1 isolate (1%); and L. kirschneri sv Grippotyphosa 1 isolate (1%).

A total of 78/106 patients (74%) had a positive MAT titer, and the remaining 28 patients had a negative MAT result. The 78 positive MAT results included 72 patients with a 4-fold rise in titer, 3 patients with raised titers of 1:400 or more in both acute and convalescent samples, and 3 patients with one diagnostic titer. Convalescent samples were obtained a median of 17 days (range, 5–53 days; IQR, 12–21 days) after the onset of symptoms in patients with a positive MAT and a median of 7 days (range, 3–21 days; IQR, 6–14 days) after the onset of symptoms for those with a negative MAT result (P = 0.0001). All 28 patients with a negative MAT were infected with L. interrogans serovar (sv.) Autumnalis.

Positive MAT results were divided into three groups: 1) MAT correctly assigned the serovar of the infecting isolate (highest MAT titer against the infecting serovar), which was observed in 26/78 cases (33%); 2) MAT failed to assign the serovar of the infecting isolate (highest MAT titer against a different serovar; 41/78 cases; 53%); and 3) MAT could not be interpreted in relation to the infecting serovar, because shared highest MAT titers were observed for both the correct serovar plus one or more other serovars (11/78 cases, 14%).

Of the 63 patients infected with L. interrogans sv. Autumnalis who had a positive MAT titer, the most common reactions occurring at a titer of ≥ 1:400 for serovars other than Autumnalis were seen against serovar Copenhageni (N = 29), Australis (N = 22), Cynopteri (N = 12), and Djasiman (N = 9). Fifty L. interrogans sv. Autumnalis isolates from this study have been genotyped previously using multilocus sequence typing, and all were found to belong to a single clone (sequence type [ST] 34).7 One possible explanation for this variable cross-reactivity is that minor variability between isolates in structure and/or expression of the proteins associated with a given serovar can be detected by the configuration of MAT but not by CAAT. It is also possible that determining the cut-off point in the agglutination reaction of MAT, a subtle and subjective measure, is prone to interobserver and intraobserver error.

Failure of MAT to correctly predict the infecting serovar has several possible explanations. We propose that seropositivity is high in the general population in rural Thailand, because leptospirosis is a leading cause of fever in adults presenting to hospital,4 and such severe cases probably represent a fraction of infections associated with milder clinical symptoms. The sera tested may have been collected too soon to detect antibodies to the strain causing the current infection and may have detected antibodies from a previous infection. It is also possible that sera were collected too soon after infection when more cross-reactive IgM antibody predominated.3 Median time to the second sample in this study was 15 days after presentation, and further studies are needed in our setting using an extended follow-up to determine whether this would improve the predictive accuracy of MAT for the infecting serovar.

One criticism of the study is that the MAT panel strains contained the correct serovars for the region but did not contain the actual infecting strains in Thailand during the study period. The strain of sv. Autumnalis used in the MAT panel was Akiyami A, which is genetically distant from the dominant sv. Autumnalis clone ST34 (different alleles at all seven MLST loci).7 We would argue, however, that strains used in the MAT panel are rarely an exact match for those causing disease in the developing world. This is because prior knowledge of the prevalent pathogenic strains is often lacking in resource-poor settings where leptospirosis occurs most commonly but where facilities to culture the causative organisms are usually lacking. Furthermore, the serovars causing disease in a given area can change over time, and the serovars causing leptospirosis even in neighboring countries may be distinctive and non-overlapping. We suggest that it is impractical to repeatedly alter the MAT strain panel over a short time frame and that this could be associated with improved accuracy for some countries while reducing the accuracy for others.

In conclusion, this study showed that serovar data derived from the MAT test offers a poor reflection of infecting serovars in Thailand. Culture of infecting isolates and CAAT identification of serovar remains the technique of choice during epidemiologic studies in Thailand.


Received May 9, 2009. Accepted for publication June 25, 2009.

Acknowledgments: The authors thank the director and staff of the Medical Department of Udon Thani Hospital (Udon Thani Province, Thailand),Maharaj Nakhon Ratchasima Hospital (Nakhon Ratchasima Province, Thailand), Loei Hospital (Loei Province, Thailand), Banmai Chaiyapod Hospital (Bureerum Province, Thailand), Maha Sarakham Hospital (Maha Sarakham Province, Thailand), and Yasothon Hospital (Yasothon Province, Thailand) for cooperation and Amornwadee Sungkakam, Premjit Amornchai, and Sayan Langla (Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University) for technical assistance.

Financial support: This study was funded by the Wellcome Trust.

* Address correspondence to Vanaporn Wuthiekanun, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 10400, Thailand. E-mail: lek{at}tropmedres.ac Back

Authors’ addresses: Lee D. Smythe, Michael F. Dohnt, Meegan L. Symonds, and Andrew T. Slack, WHO/FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis, Western Pacific Region, Centre for Public Health Sciences, Queensland Health Scientific Services, Brisbane, Australia. Vanaporn Wuthiekanun, Wirongrong Chierakul, Sunee Chueasuwanchai, Nicholas P. Day, and Sharon J. Peacock, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 10400, Thailand. Yupin Suputtamongkol and Surapee Tiengrim, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. Apichat Apiwattanaporn, Medical Department, Udon Thani General Hospital, Udon Thani, Thailand.

Reprint requests: Vanaporn Wuthiekanun, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 10400, Thailand, E-mail: lek{at}tropmedres.ac.

 

REFERENCES

  1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM; Peru-United States Leptospirosis Consortium, 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3: 757–771.[CrossRef][Web of Science][Medline]
  2. Ellis RD, Fukuda MM, McDaniel P, Welch K, Nisalak A, 2006. Causes of fever in adults on the Thai-Myanmar border. Am J Trop Med Hyg 74: 108–113.[Abstract/Free Full Text]
  3. Levett PN, 2001. Leptospirosis. Clin Microbiol Rev 14: 296–326.[Abstract/Free Full Text]
  4. Suttinont C, Losuwanaluk K, Niwatayakul K, Hoontrakul S, Intaranongpai W, Silpasakorn S, Suwancharoen D, Panlar P, Saisongkorh W, Rolain JM, Raoult D, Suputtamongkol Y, 2006. Causes of acute, undifferentiated, febrile illness in rural Thailand: results of a prospective observational study. Ann Trop Med Parasitol 100: 363–370.[CrossRef][Web of Science][Medline]
  5. Tangkanakul W, Smits HL, Jatanasen S, Ashford DA, 2005. Leptospirosis: an emerging health problem in Thailand. Southeast Asian J Trop Med Public Health 36: 281–288.[Medline]
  6. Levett PN, 2003. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis 36: 447–452.[CrossRef][Web of Science][Medline]
  7. Thaipadungpanit J, Wuthiekanun V, Chierakul W, Smythe LD, Petkanchanapong W, Limpaiboon R, Apiwatanaporn A, Slack AT, Suputtamongkol Y, White NJ, Feil EJ, Day NP, Peacock SJ, 2007. Emergence of a virulent clone of Leptospira interrogans as the cause of an epidemic of human leptospirosis in Thailand. PLoS Negl Trop Dis 1: e56.[CrossRef][Medline]
  8. Bureau of Epidemiology Department of Disease Control, Ministry of Public Health, Leptospirosis. Case Definition for Surveillance. ICD-10: A 27. Available at: http://203.157.15.4/publish/cdsur/BEWARE/Leptospirosis.htm. Accessed 2000.
  9. Faine S, Adler B, Bolin C, Perolat P, 1999. Leptospira and Leptospirosis, 2nd Edition. Melbourne, Australia: MediSci.
  10. Stallman N, 1984. International Committee on Systematic Bacteriology, Subcommittee on the Taxonomy of Leptospira: minutes of the meeting, 6 to 10 August 1982, Boston, Massachusetts. Int J Syst Bacteriol 34: 258–259.[Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Smythe, L. D.
Right arrow Articles by Peacock, S. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smythe, L. D.
Right arrow Articles by Peacock, S. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS